Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 102: 129670, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38387692

ABSTRACT

Histone deacetylase 6 (HDAC6) has drawn more and more attention for its potential application in Alzheimer's disease (AD) therapy. A series of tetrahydro-ß-carboline (THßC) hydroxamic acids with aryl linker were synthesized. In enzymatic assay, all compounds exhibited nanomolar IC50 values. The most promising compound 11d preferentially inhibited HDAC6 (IC50, 8.64 nM) with approximately 149-fold selectivity over HDAC1. Molecular simulation revealed that the hydroxamic acid of 11d could bind to the zinc ion by a bidentate chelating manner. In vitro, 11d induced neurite outgrowth of PC12 cells without producing toxic effects and showed obvious neuroprotective activity in a model of H2O2-induced oxidative stress.


Subject(s)
Carbolines , Histone Deacetylase Inhibitors , Hydrogen Peroxide , Rats , Animals , Histone Deacetylase 6 , Histone Deacetylase Inhibitors/pharmacology , Hydrogen Peroxide/pharmacology , Hydroxamic Acids/pharmacology , Neuronal Outgrowth , Histone Deacetylase 1/metabolism , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...